| Modified solid lipid nanoparticles encapsulated with Amphotericin B and Paromomycin: an effective oral combination against experimental murine visceral leishmaniasis S Parvez, G Yadagiri, MR Gedda, A Singh, OP Singh, A Verma, S Sundar, ... Scientific Reports 10 (1), 12243, 2020 | 87 | 2020 |
| Mannose-conjugated curcumin-chitosan nanoparticles: efficacy and toxicity assessments against Leishmania donovani P Chaubey, B Mishra, SL Mudavath, RR Patel, S Chaurasia, S Sundar, ... International journal of biological macromolecules 111, 109-120, 2018 | 71 | 2018 |
| Formulation, characterization and in vitro anti-leishmanial evaluation of amphotericin B loaded solid lipid nanoparticles coated with vitamin B12-stearic acid conjugate A Singh, G Yadagiri, S Parvez, OP Singh, A Verma, S Sundar, ... Materials Science and Engineering: C 117, 111279, 2020 | 39 | 2020 |
| Recuperating biopharmaceutical aspects of amphotericin B and paromomycin using a chitosan functionalized nanocarrier via oral route for enhanced anti-leishmanial activity S Parvez, G Yadagiri, A Karole, OP Singh, A Verma, S Sundar, ... Frontiers in cellular and infection microbiology 10, 570573, 2020 | 29 | 2020 |
| Envisioning the innovations in nanomedicine to combat visceral leishmaniasis: for future theranostic application OP Singh, MR Gedda, SL Mudavath, ON Srivastava, S Sundar Nanomedicine 14 (14), 1911-1927, 2019 | 29 | 2019 |
| Characterization and evaluation of amine-modified graphene amphotericin B for the treatment of visceral leishmaniasis: in vivo and in vitro studies SL Mudavath, M Talat, M Rai, ON Srivastava, S Sundar Drug Design, Development and Therapy 8, 1235-1247, 2014 | 29 | 2014 |
| Downshifting and upconversion dual mode emission from lanthanide doped GdPO4 nanorods for unclonable anti-counterfeiting BSN Pushpendra, Indranil Suryawanshi, Saumya Srinidhi, Sarabjot Singh ... Materials Today Communications, 2021 | 28 | 2021 |
| Evaluation of Safety and Antileishmanial Efficacy of Amine Functionalized Carbon-Based Composite Nanoparticle Appended With Amphotericin B: An in vitro and … MR Gedda, P Madhukar, AK Vishwakarma, V Verma, AK Kushwaha, ... Frontiers in chemistry 8, 510, 2020 | 25 | 2020 |
| Nanodiagnostics in leishmaniasis: A new frontiers for early elimination MR Gedda, P Madhukar, A Shukla, SL Mudavath, ON Srivastava, ... Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 13 (2 …, 2021 | 23 | 2021 |
| Role of STAT3 in the initiation, progression, proliferation and metastasis of breast cancer and strategies to deliver JAK and STAT3 inhibitors RJRAVJ Yirivinti Hayagreeva Dinakar, Hitesh Kumar, Shyam Lal Mudavath Life Sciences, 2022 | 22 | 2022 |
| Coalition of biological agent (melatonin) with chemotherapeutic agent (amphotericin B) for combating visceral leishmaniasis via oral administration of modified solid lipid … S Parvez, G Yadagiri, K Arora, A Javaid, AK Kushwaha, OP Singh, ... ACS Biomaterials Science & Engineering 9 (6), 2902-2910, 2021 | 17 | 2021 |
| Carboxymethyl chitosan modified lipid nanoformulations as a highly efficacious and biocompatible oral anti-leishmanial drug carrier system A Singh, G Yadagiri, M Negi, AK Kushwaha, OP Singh, S Sundar, ... International Journal of Biological Macromolecules 204, 373-385, 2022 | 15 | 2022 |
| Improvising anti-leishmanial activity of amphotericin B and paromomycin using co-delivery in d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) tailored nano-lipid … S Parvez, G Yadagiri, A Singh, A Karole, OP Singh, S Sundar, ... Chemistry and Physics of Lipids 231, 104946, 2020 | 15 | 2020 |
| Comparative evaluation of blood and serum samples in rapid immunochromatographic tests for visceral leishmaniasis D Kumar, B Khanal, P Tiwary, SL Mudavath, NK Tiwary, R Singh, ... Journal of clinical microbiology 51 (12), 3955-3959, 2013 | 15 | 2013 |
| Organ-restricted delivery through stimuli-responsive nanocarriers for lung cancer therapy YH Dinakar, A Karole, S Parvez, V Jain, SL Mudavath Life Sciences 310, 121133, 2022 | 14 | 2022 |
| Detection of latent fingerprints using luminescent Gd0. 95Eu0. 05PO4 nanorods I Suryawanshi, R Kalia, RK Kunchala, SL Mudavath, BS Naidu Journal of Rare Earths 40 (4), 572-578, 2022 | 13 | 2022 |
| Fabrication, physicochemical characterization and In vitro anticancer activity of nerolidol encapsulated solid lipid nanoparticles in human colorectal cell line S Parvez, A Karole, SL Mudavath Colloids and Surfaces B: Biointerfaces 215, 112520, 2022 | 11 | 2022 |
| Transport mechanism of hydroxy-propyl-beta-cyclodextrin modified solid lipid nanoparticles across human epithelial cells for the oral absorption of antileishmanial drugs S Parvez, A Karole, SL Mudavath Biochimica et Biophysica Acta (BBA)-General Subjects 1866 (8), 130157, 2022 | 9 | 2022 |
| Immunotherapy and immunochemotherapy in combating visceral leishmaniasis G Yadagiri, A Singh, K Arora, SL Mudavath Frontiers in Medicine 10, 1096458, 2023 | 8 | 2023 |
| Effervescent based nano-gas carrier enhanced the bioavailability of poorly aqueous soluble drug: A comprehensive mechanistic understanding A Karole, S Parvez, RS Thakur, SL Mudavath Journal of Drug Delivery Science and Technology 69, 103167, 2022 | 8 | 2022 |
Om Prakash Singh, M.Phil, PhDAssistant Professor, Department of Biochemistry; & Scientist, Department of Medicine, Banaras HinduVerified email at bhu.ac.in
